Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Level of attitude toward complementary and alternative medicine among Iranian patients with multiple sclerosis.
The formation of inflammatory demyelinated lesions in cerebral white matter.
Modulating neurotoxicity through CX3CL1/CX3CR1 signaling.
The role of transcriptional control in multiple system atrophy.
A molecular view of multiple sclerosis and experimental autoimmune encephalitis: What can we learn from the epitope data?
When does multiple sclerosis start? Three case reports and a review of the literature.
Optimizing treatment initiation: Effects of a patient education program about fingolimod treatment on knowledge, self-efficacy and patient satisfaction.
Risk of progressive multifocal leukoencephalopathy in patients with multiple sclerosis.
In vivo imaging of system xc- as a novel approach to monitor multiple sclerosis.
Industry Update: The latest developments in therapeutic delivery.
New analysis indicates that Novartis drug Gilenya shows significant early effect on reducing brain volume loss at 6 months
Characterization of In Vitro Expanded Bone Marrow-Derived Mesenchymal Stem Cells Isolated from Experimental Autoimmune Encephalomyelitis Mice.
Optic neuropathies: characteristic features and mechanisms of retinal ganglion cell loss.
Interferon-Beta Induces Distinct Gene Expression Response Patterns in Human Monocytes versus T cells.
Sulfocerebrosides upregulate liposome uptake in human astrocytes without inducing a proinflammatory response.
Novel Therapeutic Approach by Nicotine in Experimental Model of Multiple Sclerosis.
Prevalence of Sexual Dysfunctions Among Women with Multiple Sclerosis.
Hospitalization rates and discharge status in multiple sclerosis.
Functionally Relevant White Matter Degradation in Multiple Sclerosis: A Tract-based Spatial Meta-Analysis.
Clinical associations between gout and multiple sclerosis, Parkinson's disease and motor neuron disease: record-linkage studies.
Multifocal visual evoked potential in optic neuritis, ischemic optic neuropathy and compressive optic neuropathy.
Optic nerve diffusion tensor imaging after acute optic neuritis predicts axonal and visual outcomes.
Interactions and tradeoffs between cell recruitment, proliferation, and differentiation affect CNS regeneration.
Relevance of CD34+ Cells as a Reservoir for JC Virus in Patients With Multiple Sclerosis.
Duloxetine for the Treatment of Overactive Bladder Syndrome in Multiple Sclerosis: A Pilot Study.
Pages
« first
‹ previous
…
372
373
374
375
376
377
378
379
380
…
next ›
last »